Frontiers in Neuroscience Seminar - Modulation of microglia activation in Alzheimer’s disease- a future treatment strategy?

Join us on March 26, for a Frontiers in Neuroscience Seminar featuring our invited speaker Professor Michael T. Heneka from the University of Luxembourg.

Talk title: Modulation of microglia activation in Alzheimer’s disease- a future treatment strategy?

Time: 16:00
Where: Segerfalksalen, BMC A10
 

About the speaker: 
Michael T. Heneka is a leading scientist in neuroimmunology and a key contributor to our understanding of how innate immune mechanisms drive neurodegeneration. He is affiliated with the University of Luxembourg, where he serves as Professor and leads research in neuroinflammation and neurodegenerative disease. Trained as a neurologist and neuroscientist, Heneka has been instrumental in shifting the field beyond a neuron-centric perspective, highlighting the active role of immune processes in disorders such as Alzheimer's disease.
A central focus of his research is microglia, the brain’s resident innate immune cells. Heneka’s work has been particularly influential in demonstrating how activation of the NLRP3 inflammasome in microglia links amyloid-β pathology to chronic neuroinflammation and cognitive decline. These findings helped establish neuroinflammation as a driving force—rather than a mere consequence—of Alzheimer’s pathology. By uncovering molecular connections between protein aggregation and innate immune signaling, Heneka has opened new therapeutic avenues aimed at modulating microglial function in neurodegenerative disease.